The global AI Pathology Analysis System market size is predicted to grow from US$ 115 million in 2025 to US$ 293 million in 2031; it is expected to grow at a CAGR of 16.8% from 2025 to 2031.
The AI pathology analysis system is a medical diagnostic tool based on artificial intelligence technology. It automatically analyzes and identifies pathology slice images through deep learning algorithms, assisting pathologists in quickly and accurately detecting diseases such as cancer and inflammation. The system can extract features from massive pathology data, identify subtle lesions, and provide diagnostic suggestions, significantly improving diagnostic efficiency and accuracy while reducing human errors, providing strong support for precision medicine and personalized treatment.
Segmentation by Type
- On-premises
- Cloud-based
Segmentation by Application
- Hospital
- Clinic
- Others
Market by Region
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
Company Coverage
- Visiopharm
- PathAI
- Aiforia
- Indica Labs
- aetherAI
- Proscia
- Mindpeak
- Techcyte
- Qritive
- Deepathology
- Franklin.ai
- Roche Diagnostics
- Flagship
- Dedalus Group
- Ibex Medical Analytics
Key Questions Addressed in this Report
Frequently Asked Questions
What is the USP of the report? expand_more
What are the key content of the report? expand_more
- Global Market Players
- Geopolitical regions
- Consumer Insights
- Technological advancement
- Historic and Future Analysis of the Market